Terapevticheskii arkhivTerapevticheskii arkhivТерапевтический архив0040-36602309-5342LLC Obyedinennaya Redaktsiya3302310.26442/00403660.2019.03.000185Editorial articleПередовая статьяReview ArticleExpert Council resolution on pulmonary arterial hypertension (PAH) "Changing the paradigm of treating patients with pulmonary arterial hypertension"Резолюция экспертного совета по проблеме легочной артериальной гипертензии (ЛАГ) «Меняя парадигму лечения пациентов с легочной артериальной гипертензией»ChazovaI EЧазоваИрина Евгеньевна
акад. РАН, д.м.н., проф., директор, руководитель отд. гипертонии; ORCID: 0000-0002-9822-4357
MartynyukT VМартынюкТамила Витальевна
д.м.н., руководитель отд. легочной гипертензии и заболеваний сердца
Galie N, Manes A, Negro L, et al. A meta - analysis of randomized controlled trials pulmonary arterial hypertension. Eur Heart J. 2009;30:394-403. doi: 10.1093/eurheartj/ehp022D'Alonzo G.E, Barst R.J, Ayres S.M, et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med. 1991;115(5):343-49.Kane G.C, Maradit-Kremers H, Slusser J, et al. Integration of Clinical and Hemodynamic Parameters in the Prediction of Long - term Survival in Patients With Pulmonary Arterial Hypertension. Chest. 2011;139(6):1285-93.Humbert M, Sitbon O, Chaouat A, et al. Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med. 2006;173:1023-30. doi:10.1164/rccm.200510-1668OCHoeper M.M, Kramer T, Pan Z, et al. Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model. Eur Respir J. 2017;50(2). doi: 10.1183/13993003.00740-2017Волков А.В., Мартынюк Т.В., Юдкина Н.Н., Данилов Н.М., Глухова С.И., Гусева Н.Г., Чазова И.Е., Насонова В.А. Выживаемость пациентов с легочной артериальной гипертензией, ассоциированной с системной склеродермией. Терапевтический архив. 2012;84(5):24-8.Kylhammar D, Kjellström B, Hjalmarsson C, et al. A comprehensive risk stratification at early follow - up determines prognosis in pulmonary arterial hypertension. Eur Respir J. 2017 Aug 3;50(2). doi: 10.1183/13993003.00889-2017Boucly A, Weatherald J, Savale L, et al. Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension. Eur Respir J. 2017 Aug 3;50(2):pii: 1700889. doi: 10.1183/13993003.00889-2017Hoeper M.M, Huscher D, Ghofrani H.A, et al. Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: Results from the COMPERA registry. Intern J Cardiology. 2013;168(2):871-80. doi: 10. 1016/j.ijcard.2012.10.026Galie N, Humbert M, Vachiery J.L, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Eur Respir J. 2015;46(4):903-75. doi:10.1183/13993003.01032-2015ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association. Circulation. 2009;119:2250-94. doi: 10.1161/CIRCULATIONAHA.109.192230Федеральные рекомендации по диагностике и лечению легочной гипертензии. http://cr.rosminzdrav.ru/ [Federal recommendations for the diagnosis and treatment of pulmonary hypertension (In Russ.)].Sitbon O, Channick R, Chin K.M, et al. Selexipag for the treatment of pulmonary arterial hypertension. N Engl J Med. 2015;373:2522-33. doi:10.1056/NEJMoa1503184